JP2013544256A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544256A5
JP2013544256A5 JP2013540089A JP2013540089A JP2013544256A5 JP 2013544256 A5 JP2013544256 A5 JP 2013544256A5 JP 2013540089 A JP2013540089 A JP 2013540089A JP 2013540089 A JP2013540089 A JP 2013540089A JP 2013544256 A5 JP2013544256 A5 JP 2013544256A5
Authority
JP
Japan
Prior art keywords
pyridin
thiazol
amino
methyl
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013540089A
Other languages
English (en)
Japanese (ja)
Other versions
JP6005050B2 (ja
JP2013544256A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/061532 external-priority patent/WO2012068546A1/en
Publication of JP2013544256A publication Critical patent/JP2013544256A/ja
Publication of JP2013544256A5 publication Critical patent/JP2013544256A5/ja
Application granted granted Critical
Publication of JP6005050B2 publication Critical patent/JP6005050B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013540089A 2010-11-19 2011-11-18 複素環式アミンおよびその使用 Active JP6005050B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41568510P 2010-11-19 2010-11-19
US61/415,685 2010-11-19
PCT/US2011/061532 WO2012068546A1 (en) 2010-11-19 2011-11-18 Heterocycle amines and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016171817A Division JP6316888B2 (ja) 2010-11-19 2016-09-02 複素環式アミンおよびその使用

Publications (3)

Publication Number Publication Date
JP2013544256A JP2013544256A (ja) 2013-12-12
JP2013544256A5 true JP2013544256A5 (enExample) 2016-03-24
JP6005050B2 JP6005050B2 (ja) 2016-10-12

Family

ID=45094285

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013540089A Active JP6005050B2 (ja) 2010-11-19 2011-11-18 複素環式アミンおよびその使用
JP2016171817A Active JP6316888B2 (ja) 2010-11-19 2016-09-02 複素環式アミンおよびその使用
JP2018059583A Active JP6726226B2 (ja) 2010-11-19 2018-03-27 複素環式アミンおよびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016171817A Active JP6316888B2 (ja) 2010-11-19 2016-09-02 複素環式アミンおよびその使用
JP2018059583A Active JP6726226B2 (ja) 2010-11-19 2018-03-27 複素環式アミンおよびその使用

Country Status (14)

Country Link
US (5) US9266874B2 (enExample)
EP (3) EP3357915A1 (enExample)
JP (3) JP6005050B2 (enExample)
KR (2) KR101903204B1 (enExample)
CN (2) CN108864151A (enExample)
ES (1) ES2672203T3 (enExample)
HK (1) HK1252165A1 (enExample)
HU (1) HUE037860T2 (enExample)
MX (3) MX388008B (enExample)
PL (1) PL2730564T3 (enExample)
PT (1) PT2730564T (enExample)
RS (1) RS57375B1 (enExample)
RU (2) RU2632900C2 (enExample)
WO (1) WO2012068546A1 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201270778A1 (ru) * 2010-05-06 2013-04-30 Бристол-Майерс Сквибб Компани Бициклические гетероарильные аналоги в качестве модуляторов рецептора gpr119
WO2013169382A1 (en) * 2012-05-07 2013-11-14 DePuy Synthes Products, LLC Methods and devices for treating intervertebral disc disease
WO2014074657A1 (en) * 2012-11-08 2014-05-15 Bristol-Myers Squibb Company Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
RU2016110852A (ru) * 2013-09-27 2017-10-30 Нимбус Айрис, Инк. Ингибиторы irak и их применения
EP3089746A4 (en) * 2013-12-30 2017-08-30 Lifesci Pharmaceuticals, Inc. Therapeutic inhibitory compounds
SMT202400142T1 (it) 2014-01-13 2024-05-14 Aurigene Oncology Ltd Enantiomeri (r) e (s) di n-(5-(3-idrossipirrolidin-1-il)-2-morfolinoossazolo[4,5-b]piridin-6-il)-2-(2-metilpiridin-4-il)ossazolo-carbossammide in qualità di inibitori di irak4 per il trattamento di un cancro
AU2016252869B2 (en) 2015-04-22 2020-10-22 Rigel Pharmaceuticals, Inc. Pyrazole compounds and method for making and using the compounds
KR20180026537A (ko) * 2015-07-15 2018-03-12 오리진 디스커버리 테크놀로지스 리미티드 Irak-4 저해제로서 치환된 아자 화합물
AU2016323612B2 (en) * 2015-09-18 2021-04-08 Merck Patent Gmbh Heteroaryl compounds as IRAK inhibitors and uses thereof
WO2017102091A1 (en) 2015-12-18 2017-06-22 Bayer Pharma Aktiengesellschaft Heteroarylbenzimidazole compounds
WO2017207534A1 (en) 2016-06-03 2017-12-07 Bayer Pharma Aktiengesellschaft Substituted heteroarylbenzimidazole compounds
JOP20180011A1 (ar) 2017-02-16 2019-01-30 Gilead Sciences Inc مشتقات بيرولو [1، 2-b]بيريدازين
EP4252853A3 (en) 2017-03-31 2023-12-13 Aurigene Oncology Limited Compounds and compositions for treating hematological disorders
WO2018234342A1 (en) * 2017-06-21 2018-12-27 F. Hoffmann-La Roche Ag Isoindolinone derivatives as irak4 modulators
AU2018338314B2 (en) 2017-09-22 2024-12-12 Kymera Therapeutics, Inc Protein degraders and uses thereof
WO2019060693A1 (en) 2017-09-22 2019-03-28 Kymera Therapeutics, Inc. CRBN LIGANDS AND USES THEREOF
PL3704108T3 (pl) 2017-10-31 2024-07-22 Curis, Inc. Inhibitor irak4 w połączeniu z inhibitorem bcl-2 do stosowania w leczeniu nowotworu złośliwego
WO2019111218A1 (en) 2017-12-08 2019-06-13 Cadila Healthcare Limited Novel heterocyclic compounds as irak4 inhibitors
IL315310A (en) 2017-12-26 2024-10-01 Kymera Therapeutics Inc Irak degraders and uses thereof
EP3737675A4 (en) 2018-01-12 2022-01-05 Kymera Therapeutics, Inc. Crbn ligands and uses thereof
EP3737666A4 (en) 2018-01-12 2022-01-05 Kymera Therapeutics, Inc. PROTEIN DEGRADATION AGENTS AND ASSOCIATED USES
WO2020010227A1 (en) 2018-07-06 2020-01-09 Kymera Therapeutics, Inc. Protein degraders and uses thereof
EP3817748A4 (en) 2018-07-06 2022-08-24 Kymera Therapeutics, Inc. TRICYCLIC CRBN LIGANDS AND USES THEREOF
TWI842978B (zh) 2018-07-13 2024-05-21 美商基利科學股份有限公司 衍生物
EP3876930A4 (en) 2018-11-07 2022-07-20 Dana-Farber Cancer Institute, Inc. BENZIMIDAZOLE DERIVATIVES AND AZA-BENZIMIDAZOLE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND THEIR USES
US12415816B2 (en) 2018-11-07 2025-09-16 Dana-Farber Cancer Institute, Inc. Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
EP3877371A4 (en) 2018-11-07 2022-07-27 Dana-Farber Cancer Institute, Inc. IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES USED AS JANUS KINASE 2 INHIBITORS AND ASSOCIATED USES
SG11202105424PA (en) 2018-11-30 2021-06-29 Kymera Therapeutics Inc Irak degraders and uses thereof
CN114174304B (zh) * 2019-07-23 2024-05-17 百时美施贵宝公司 可用作irak4抑制剂的噻吩并吡啶基化合物和噻唑并吡啶基化合物
EP4003990A1 (en) 2019-08-30 2022-06-01 Rigel Pharmaceuticals, Inc. Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations
JP7370109B2 (ja) * 2019-10-04 2023-10-27 パレンキマ バイオテック インコーポレイテッド 新規化合物およびその自己免疫疾患の治療用途
WO2021127283A2 (en) 2019-12-17 2021-06-24 Kymera Therapeutics, Inc. Irak degraders and uses thereof
JP2023509366A (ja) 2019-12-17 2023-03-08 カイメラ セラピューティクス, インコーポレイテッド Irak分解剤およびそれらの使用
WO2021226261A1 (en) 2020-05-06 2021-11-11 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
TW202210483A (zh) 2020-06-03 2022-03-16 美商凱麥拉醫療公司 Irak降解劑之結晶型
KR102871840B1 (ko) 2020-09-30 2025-10-15 아사히 가세이 파마 가부시키가이샤 거대고리 화합물
JP7433463B2 (ja) * 2020-09-30 2024-02-19 旭化成ファーマ株式会社 ピリミジン含有含窒素二環化合物
EP4267574B1 (en) 2020-12-23 2025-04-23 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
MX2023007852A (es) 2020-12-30 2023-07-07 Kymera Therapeutics Inc Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
WO2022174268A1 (en) 2021-02-15 2022-08-18 Kymera Therapeutics, Inc. Irak4 degraders and uses thereof
IL304905A (en) 2021-02-15 2023-10-01 Kymera Therapeutics Inc IRAK4 joints and their uses
US12357623B2 (en) 2021-03-03 2025-07-15 Rigel Pharmaceuticals, Inc. Method for treating a disease or condition using a pyrazole compound or formulation thereof
PH12023552792A1 (en) 2021-04-08 2024-05-20 Curis Inc Combination therapies for the treatment of cancer
AU2022271290A1 (en) 2021-05-07 2023-11-23 Kymera Therapeutics, Inc. Cdk2 degraders and uses thereof
WO2023076556A1 (en) 2021-10-29 2023-05-04 Kymera Therapeutics, Inc. Irak4 degraders and synthesis thereof
JP7782035B2 (ja) 2021-11-09 2025-12-08 エイジャックス セラピューティクス, インコーポレイテッド Jak2阻害剤としての6-ヘテロアリールオキシベンゾイミダゾール及びアザベンゾイミダゾール
WO2023086320A1 (en) 2021-11-09 2023-05-19 Ajax Therapeutics, Inc. Forms and compositions of inhibitors of jak2
IL314437A (en) 2022-01-31 2024-09-01 Kymera Therapeutics Inc IRAK joints and their uses
JP2025513716A (ja) 2022-03-23 2025-04-30 ライジェル・ファーマシューティカルズ・インコーポレイテッド Irak阻害剤としてのピリミド-2-イル-ピラゾール化合物
TW202345806A (zh) 2022-03-31 2023-12-01 美商艾伯維有限公司 噻唑并〔5,4-b〕吡啶malt-1抑制劑
CN118239953A (zh) * 2022-12-23 2024-06-25 中国科学院合肥物质科学研究院 用于治疗PI3Kγ介导的疾病的化合物及其用途

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5542990B2 (enExample) * 1972-01-27 1980-11-04
US6124330A (en) * 1996-06-27 2000-09-26 Janssen-Cilag S.A. N-[4-(Heteroarylmethyl)phenyl]-heteroarylamines
DE69833224T2 (de) 1997-11-10 2006-09-28 Bristol-Myers Squibb Co. Benzothiazole als protein tyrosin-kinase inhibitoren
JP2000086641A (ja) * 1998-09-11 2000-03-28 Kyorin Pharmaceut Co Ltd 2−置換ベンゾチアゾール誘導体及びその製造法
MXPA04009541A (es) * 2002-03-29 2005-01-25 Chiron Corp Benzazoles sustituidos y uso de los mismos como inhibidores de cinasa raf.
US20040023978A1 (en) * 2002-07-24 2004-02-05 Yu Ren Active salt forms with tyrosine kinase activity
US7531553B2 (en) * 2003-03-21 2009-05-12 Amgen Inc. Heterocyclic compounds and methods of use
US20070066577A1 (en) * 2003-04-03 2007-03-22 Hea Young Park Choo Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same
AU2004278382B2 (en) 2003-09-30 2008-09-18 Amgen Inc. Vanilloid receptor ligands and their use in treatments
CN1882345A (zh) * 2003-10-16 2006-12-20 希龙公司 作为raf激酶抑制剂以治疗癌症的2,6-二取代的喹唑啉、喹喔啉、喹啉和异喹啉
US7714009B2 (en) 2003-10-31 2010-05-11 Takeda Pharmaceutical Company Limited Nitrogen-containing fused heterocyclic compounds
GB0401334D0 (en) * 2004-01-21 2004-02-25 Novartis Ag Organic compounds
EP1674466A1 (en) 2004-12-27 2006-06-28 4Sc Ag 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
US7473784B2 (en) * 2005-08-01 2009-01-06 Bristol-Myers Squibb Company Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
WO2007058482A1 (en) * 2005-11-16 2007-05-24 Lg Life Sciences, Ltd. Novel inhibitors of protein kinase
CN101360707A (zh) * 2005-11-23 2009-02-04 利亘制药公司 血小板生成素活性调节化合物和方法
EP1981343B8 (en) * 2006-01-17 2015-06-24 Stiefel Laboratories, Inc. Treatment of inflammatory disorders with triazole compounds
CA2637172A1 (en) * 2006-01-27 2007-08-09 Array Biopharma Inc. Pyridin-2-amine derivatives and their use as glucokinase activators
WO2007121154A2 (en) * 2006-04-11 2007-10-25 Janssen Pharmaceutica, N.V. Substituted benzothiazole kinase inhibitors
CN101558059B (zh) * 2006-08-11 2014-12-03 百时美施贵宝公司 丙型肝炎病毒抑制剂
EP2063962A2 (en) * 2006-09-07 2009-06-03 Biogen Idec MA Inc. Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder
CA2663100A1 (en) * 2006-09-07 2008-03-13 Biogen Idec Ma Inc. Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
JP2008255024A (ja) * 2007-04-02 2008-10-23 Banyu Pharmaceut Co Ltd ビアリールアミン誘導体
WO2009126635A1 (en) 2008-04-09 2009-10-15 Abbott Laboratories 2-amino-benzothiazole derivates useful as inhibitors of rock kinases
JPWO2009128520A1 (ja) * 2008-04-18 2011-08-04 塩野義製薬株式会社 Pi3k阻害活性を有する複素環化合物
US8420052B2 (en) * 2008-07-24 2013-04-16 Siemens Medical Solutions Usa, Inc. Imaging agents useful for identifying AD pathology
JP5177076B2 (ja) 2008-07-28 2013-04-03 日産自動車株式会社 車両運転支援装置及び車両運転支援方法
TWI396689B (zh) * 2008-11-14 2013-05-21 Amgen Inc 作為磷酸二酯酶10抑制劑之吡衍生物
US9067947B2 (en) * 2009-01-16 2015-06-30 Universal Display Corporation Organic electroluminescent materials and devices
JP2012519177A (ja) * 2009-02-27 2012-08-23 バーテックス ファーマシューティカルズ インコーポレイテッド 三環式ピラゾロピリジンキナーゼインヒビター
WO2010106016A1 (en) * 2009-03-17 2010-09-23 Glaxo Group Limited Pyrimidine derivatives used as itk inhibitors
CN102480966B (zh) * 2009-06-12 2015-09-16 达娜-法勃肿瘤研究所公司 融合的杂环化合物及其用途
WO2011110575A1 (en) * 2010-03-11 2011-09-15 Glaxo Group Limited Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
WO2012035055A1 (en) * 2010-09-17 2012-03-22 Glaxo Group Limited Novel compounds
MA52856B1 (fr) 2014-04-04 2022-03-31 Pfizer Composés bicycliques hétéroaryle ou aryle fusionnés et leur utilisation en tant qu'inhibiteurs irak4

Similar Documents

Publication Publication Date Title
JP2013544256A5 (enExample)
RU2013124101A (ru) Гетероциклические амины и их применения
HRP20210094T1 (hr) POSTUPAK PRIPRAVE DERIVATIVA OKSAZOLO[4,5-b]PIRIDINA I TIAZOLO[4,5-b]PIRIDINA KAO INHIBITORA IRAK4 NAMIJENJENIH LIJEČENJU RAKA
JP7028861B2 (ja) ピリジル置換のインドール化合物
AU2016240033B2 (en) 1-cyano-pyrrolidine compounds as USP30 inhibitors
KR101819433B1 (ko) 인돌린-2-온 또는 피롤로-피리딘-2-온 유도체
JP4968860B2 (ja) アニリノピペラジン誘導体およびアニリノピペラジン誘導体を使用する方法
RU2401265C2 (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
CA3211347A1 (en) Indazole based compounds and associated methods of use
CA2671744A1 (en) Compounds and compositions as protein kinase inhibitors
JP2014521711A5 (enExample)
AU2007214462A1 (en) PI-3 kinase inhibitors and methods of their use
JPWO2005063743A1 (ja) チアゾール誘導体
JP2014501269A5 (enExample)
JP2013533300A (ja) ブルトン型チロシンキナーゼの阻害剤
JP2012525395A5 (enExample)
JP2005526814A5 (enExample)
US20160060222A1 (en) Amino-quinolines as kinase inhibitors
WO2017210545A1 (en) Potassium channel modulators
HRP20221454T1 (hr) Piridinamin-piridonski i pirimidinamin-piridonski spojevi
IL274198B1 (en) Use of Nox inhibitors to treat cancer
JP2023546352A (ja) Bcr-ablチロシンキナーゼの阻害のための5-及び6-アザインドール化合物
JPWO2020203609A5 (enExample)
WO2024184550A1 (en) Biarylamide derivatives and their use as pkmyt1 inhibitors